Wolfe Laboratories expands its integrated pharmaceutical development operations

WOBURN, MASS., February 16, 2016 — Wolfe Laboratories, Inc., a leading contract research organization (CRO) that provides integrated pharmaceutical development services for biotechnology and pharmaceutical companies, today announced its expansion of the company's analytical, formulation and process development capabilities. Wolfe Laboratories has relocated to its 17,595 square feet of state-of-the-art laboratory and office space at 19 Presidential Way in Woburn, Massachusetts. The expansion builds upon Wolfe Laboratories’ existing pharmaceutical development capabilities, and will support continued innovation in the development of small molecules, biologics, antibody drug conjugates and nucleic acid therapeutics. Wolfe Laboratories’ clients depend upon its expeditious scientific acumen of their development programs, which support IND enabling, clinical advancement and commercialization of innovative drug products.

"Wolfe Laboratories’ current project backlog has grown substantially over the past 12 months, and the new facility will allow us to meet our clients’ needs, as well as accommodate additional, anticipated growth. Our projects include the development of complex dosage forms, as well as the development and GMP validation of the associated characterization and analytical tools required by regulatory agencies,” said Janet Wolfe, Ph.D., Chief Executive Officer of Wolfe Laboratories.  "Since its founding, Wolfe Laboratories has made the Greater Boston area its home, actively contributing to the growth and sustainability of one of the the world's leading centers for the life sciences, attracting top-tier talent, and providing cutting-edge research and development services.  Our clients appreciate our close proximity to them and their biotechnology and pharmaceutical partners, medical centers, academic laboratories and our vibrant business community."

McCall and Almy represented Wolfe Laboratories in its real estate search and lease negotiation.

About Wolfe Laboratories

Wolfe Laboratories, Inc. is a premier contract research organization that provides integrated drug development solutions to the biopharmaceutical industry. Wolfe Laboratories is an essential element of the drug development ecosystem, recognized by global and virtual biopharmaceutical companies as a science-driven organization whose mission is to provide outstanding discovery and development services tailored to its clients’ needs for rational formulation development. Wolfe Laboratories integrates the critical path components of early development to ensure that programs advance while meeting rigorous scientific demands with flexibility to address dynamic challenges and aggressive timelines. Wolfe Laboratories’ vision is to improve human health, and we continue to strive towards that goal by embracing our core values of integrity, excellence and teamwork. The company has a high percentage of repeat clients, which is a testament to its long-term commitment of continual investment in its capabilities to meet biopharma's growing demand for high quality, integrated early development services. Founded in 1999, the company is located in Woburn, Massachusetts.

For more information, please visit www.wolfelabs.com